[4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone

C31H27F3N4OS — CID 44524082

IUPAC[4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone
SMILESO=C(c1ccc(-c2ccc(-c3nc4ccc(C(F)(F)F)cc4[nH]3)s2)cc1)N1CCN(CCc2ccccc2)CC1
InChIInChI=1S/C31H27F3N4OS/c32-31(33,34)24-10-11-25-26(20-24)36-29(35-25)28-13-12-27(40-28)22-6-8-23(9-7-22)30(39)38-18-16-37(17-19-38)15-14-21-4-2-1-3-5-21/h1-13,20H,14-19H2,(H,35,36)
InChIKeyDJLKNUBTQXXGKD-UHFFFAOYSA-N
MW560.65 g/mol
LogP6.98
Rot. Bonds6

About [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone

[4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone (PubChem CID 44524082) has the molecular formula C31H27F3N4OS and a molecular weight of 560.65 g/mol. Its IUPAC name is [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone.

Molecular Properties

Compound Name[4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone
PubChem CID44524082
Molecular FormulaC31H27F3N4OS
Molecular Weight560.65 g/mol
Exact Mass560.19
IUPAC Name[4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone
SMILESO=C(c1ccc(-c2ccc(-c3nc4ccc(C(F)(F)F)cc4[nH]3)s2)cc1)N1CCN(CCc2ccccc2)CC1
InChIInChI=1S/C31H27F3N4OS/c32-31(33,34)24-10-11-25-26(20-24)36-29(35-25)28-13-12-27(40-28)22-6-8-23(9-7-22)30(39)38-18-16-37(17-19-38)15-14-21-4-2-1-3-5-21/h1-13,20H,14-19H2,(H,35,36)
InChIKeyDJLKNUBTQXXGKD-UHFFFAOYSA-N
XLogP6.98
TPSA52.23 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500560.65
LogP ≤ 56.98
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone?
The IUPAC name of [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone (CID 44524082) is [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone.
What is the SMILES notation for [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone?
The canonical SMILES for [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone is O=C(c1ccc(-c2ccc(-c3nc4ccc(C(F)(F)F)cc4[nH]3)s2)cc1)N1CCN(CCc2ccccc2)CC1.
What is the InChIKey of [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone?
The InChIKey is DJLKNUBTQXXGKD-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H27F3N4OS/c32-31(33,34)24-10-11-25-26(20-24)36-29(35-25)28-13-12-27(40-28)22-6-8-23(9-7-22)30(39)38-18-16-37(17-19-38)15-14-21-4-2-1-3-5-21/h1-13,20H,14-19H2,(H,35,36).
What are the key properties of [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone?
[4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone has a molecular weight of 560.65 g/mol, XLogP of 6.98, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [4-(2-phenylethyl)piperazin-1-yl]-[4-[5-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]thiophen-2-yl]phenyl]methanone is sourced from PubChem (CID 44524082), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).